Higgins Jack: insider trades.
Higgins Jack reported 4 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 1 sale ($334K), across 1 company.
- Transactions
- 4
- Purchases (P)
- 0
- Sales (S)
- 1
- Companies
- 1
- Name as filed
- Higgins Jack
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Immunome Inc. (IMNM) | Officer · Chief Scientific Officer | 4 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-11 | Immunome Inc. | G | 8,800 | $0 | 56,250 | Form 4 |
| 2026-09-11 | Immunome Inc. | S | 13,200 | $25.32 | 65,050 | Form 4 |
| 2026-09-11 | Immunome Inc. | M | 18,000 | $1.35 | 78,250 | Form 4 |
| 2026-07-23 | Immunome Inc. | A | 38,250 | $0 | 60,250 | Form 4 |
Questions
What stock did Higgins Jack buy or sell?
Higgins Jack reported 4 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 1 sale ($334K), across 1 company.
Is Higgins Jack the same person as other filers with this name?
This page covers SEC CIK 1993684 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/higgins-jack-1993684.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.